Eikon Therapeutics, Inc. (EIKN): SCHEDULE 13G filed Feb 18, 2026

Form type

SCHEDULE 13G

Filing date

Feb 18, 2026

Accession number

0001999371-26-003632

Filer

Eikon Therapeutics, Inc. (CIK 1861123)